Documents | EPAD | European Prevention of Alzheimer's Dementia Consortium

Name	Downloads	Version	Owner	Last Modified	Rating
Name	Downloads	Version	Owner	Last Modified	Rating
Publications
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort » Application of the ATN classification scheme in a population without dementia Findings from the EPAD cohort.pdf File Options Download Description Preview Other Versions Goto Post	96 downloads	1.1	EPAD Administrator3	06-04-2021
Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer’s Dementia (EPAD) V500.0 Cohort » Multimorbidity and Cerebrospinal Fluid Amyloid_2019.pdf File Options Download Description Preview Other Versions Goto Post	579 downloads	1.1	EPAD Administrator3	16-08-2019
At, with and beyond risk: expectations of living with the possibility of future dementia » At with and beyond risk_2018.pdf File Options Download Description Preview Other Versions Goto Post	847 downloads	1.1	EPAD Administrator3	16-04-2018
Brain Amyloid Pathology and Cognitive Function Alzheimer Disease Without Dementia? » jama_2017.pdf File Options Download Description Preview Other Versions Goto Post	1359 downloads	1.0.1	EPAD Administrator3	13-06-2017
Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Results from the European Prevention of Alzheimer’s Dementia (EPAD) v500.0 Cohort » Cognitive_dispersion_2020.pdf File Options Download Description Preview Other Versions Goto Post	242 downloads	1.1	EPAD Administrator3	11-09-2020
Cognitive Functions as Predictors of Alzheimer’s Disease Biomarker Status in the European Prevention of Alzheimer’s Dementia Cohort » Cognive functions as predictor of ALzheimers disease 2020.pdf File Options Download Description Preview Other Versions Goto Post	401 downloads	1.1	EPAD Administrator3	05-03-2020
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility » Detective cognitive changes in preclinal AD.pdf File Options Download Description Preview Other Versions Goto Post	1569 downloads	1.1	EPAD Administrator	01-10-2016
Development of interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzheimer’s Dementia (EPAD) project » abstractlancetpaper2015.pdf File Options Download Description Preview Other Versions Goto Post	1518 downloads	1.0	EPAD Administrator	09-12-2015
Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion » Ethical_arguments_2018.pdf File Options Download Description Preview Other Versions Goto Post	562 downloads	1.1	EPAD Administrator3	12-12-2018
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit » abstract_ethical_challenges_2016.pdf File Options Download Description Preview Other Versions Goto Post	1147 downloads	1.0	EPAD Administrator3	15-03-2016
Ethical issues in the development of readiness cohorts in Alzheimer’s disease research » abstract_ethical_issues_2017.pdf File Options Download Description Preview Other Versions Goto Post	1225 downloads	1.0	EPAD Administrator3	22-02-2017
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials » EPAD_Registry_2018.pdf File Options Download Description Preview Other Versions Goto Post	769 downloads	1.1	EPAD Administrator3	28-03-2018
European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol » EPAD LCS Study Protocol 2018.pdf File Options Download Description Preview Other Versions Goto Post	771 downloads	1.0	EPAD Administrator3	27-12-2018
Evaluating the Alzheimer's disease data landscape » Evaluating the Alzheimer disease data landscape.pdf File Options Download Description Preview Other Versions Goto Post	144 downloads	1.0	EPAD Administrator3	16-12-2020
Evolution and future directions for the concept of mild cognitive impairment » evolution_future_directions_2017.pdf File Options Download Description Preview Other Versions Goto Post	826 downloads	1.0	EPAD Administrator3	13-12-2017
Involving research participants in a pan-European research initiative: the EPAD participant panel experience » EPAD resaearhc particpant panel 2020.pdf File Options Download Description Preview Other Versions Goto Post	163 downloads	1.1	EPAD Administrator3	27-10-2020
Medial temporal lobe atrophy and posterior atrophy scales normative values » Medical_temporal_2019.pdf File Options Download Description Preview Other Versions Goto Post	471 downloads	1.0	EPAD Administrator3	15-07-2019
Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease » Multi study validation_2019.pdf File Options Download Description Preview Other Versions Goto Post	475 downloads	1.0	EPAD Administrator3	23-07-2019
On the personal utility of Alzheimer’s disease-related biomarker testing in the research context » Personal utility of Alzheimer’s disease-related biomarker testing in the research context.pdf File Options Download Description Preview Other Versions Goto Post	775 downloads	1.0	EPAD Administrator3	29-08-2018
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals » Biomarker_2018.pdf File Options Download Description Preview Other Versions Goto Post	704 downloads	1.0	EPAD Administrator3	20-02-2018
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies » Precise prevention of Alzheimer's and other dementias 2020.pdf File Options Download Description Preview Other Versions Goto Post	167 downloads	1.0	EPAD Administrator3	20-08-2020
Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study » Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals1.pdf File Options Download Description Preview Other Versions Goto Post	179 downloads	1.0	EPAD Administrator3	09-11-2020
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings » Prescreening for EPAD trial-ready cohort_2020.pdf File Options Download Description Preview Other Versions Goto Post	390 downloads	1.0	EPAD Administrator3	06-01-2020
Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review » abstractrichardreview2016.pdf File Options Download Description Preview Other Versions Goto Post	1216 downloads	1.0	EPAD Administrator	10-11-2016
Re-aligning scientific and lay narratives of Alzheimer's disease » Re-aligning scientific and lay narratives of Alzheimer's disease_2019.pdf File Options Download Description Preview Other Versions Goto Post	400 downloads	1.0	EPAD Administrator3	01-10-2019
Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project » Recommended cognitive outcomes in preclinical Alzheimer’s disease.pdf File Options Download Description Preview Other Versions Goto Post	1411 downloads	1.1	EPAD Administrator	01-10-2016
Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes » Research participants as collaborators_2018.pdf File Options Download Description Preview Other Versions Goto Post	739 downloads	1.1	EPAD Administrator3	29-10-2018
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions » Secondary prevention_2018.pdf File Options Download Description Preview Other Versions Goto Post	709 downloads	1.0	EPAD Administrator3	30-10-2018
The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0 » v500.0_baseline data release_2019.pdf File Options Download Description Preview Other Versions Goto Post	421 downloads	1.0	EPAD Administrator3	26-11-2019
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries » The influence of diversity 2020.pdf File Options Download Description Preview Other Versions Goto Post	124 downloads	1.0	EPAD Administrator3	13-05-2020
The Rationale Behind the New Alzheimer’s Disease Conceptualization: Lessons Learned During the Last Decades » Rationale_Behind_New_Alzheimer's_Disease_Conceptualization_2018.pdf File Options Download Description Preview Other Versions Goto Post	752 downloads	1.0	EPAD Administrator3	13-03-2018
The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals » The relation between APOE- 2020.pdf File Options Download Description Preview Other Versions Goto Post	133 downloads	1.0	EPAD Administrator3	30-11-2020
“Ready for What” Timing and Speculation in Alzheimer’s Disease Drug Development » “Ready for What” Timing and Speculation in Alzheimer’s Disease Drug Development.pdf File Options Download Description Preview Other Versions Goto Post	11 downloads	1.0	EPAD Administrator3	22-04-2021

EPAD

@IMI_EPAD

Yesterday, we joined the @IMI_EPAD-@IMI_AMYPAD imaging workshop, aiming to engage researchers across the scientific community in the ongoing analyses currently performed in these two large European consortia, funded by @IMI_JU. #collaboration ep-ad.org/2021/06/17/epa… pic.twitter.com/q9eCOaQ770

9:49 am · 2021-06-18

EPAD

@IMI_EPAD

.@craig_ritchie68 highlights that the EPAD dataset (V.IMI) is available #openaccess on the @AlzData #ADWorkbench #ADWB at the @IMI_EPAD @IMI_AMYPAD Imaging workshop. For more information, visit our website: ep-ad.org/open-access-da… pic.twitter.com/IIElKQB3Yt

8:33 am · 2021-06-17

EPAD

@IMI_EPAD

.@craig_ritchie68 is presenting an overview of the EPAD project at the @IMI_EPAD @IMI_AMYPAD Imaging Workshop. We're looking forward to hear more about the #data availability and ongoing projects. @FBarkhof @LuigiLorenzini1 @JuandoGispert @LCollij @silvia_ingala @IMI_JU pic.twitter.com/qrGQ9ASVcV

8:29 am · 2021-06-17

EPAD

@IMI_EPAD

New paper out from @IMI_EPAD "Ready for What?: Timing and Speculation in Alzheimer’s Disease Drug Development" in @SAGEJournals. #clinicaltrials #Alzheimer’s disease #ethics #Readiness Congratulations to the authors @NFBrenman and Richard Milne 👏 ep-ad.org/2021/05/30/new… pic.twitter.com/zIeW1G9VvZ

7:57 am · 2021-06-08

EPAD

@IMI_EPAD

Exciting news ☺️👏 Great to hear that the @IMI_AMYPAD Prognostic Study will continue its enrolment and follow up of participants from @IMI_EPAD and other non-EPAD cohorts. The new timings would also facilitate the data integration across all cohorts. twitter.com/IMI_AMYPAD/sta…

7:49 am · 2021-05-05